Skip to main content

Table 4 Cardiovascular risk factors in a random subgroup (n = 11,418) of Golestan Cohort Study participants according to blood group phenotype

From: Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study

Variable Blood group
  O (number = 3,489) A (number = 3,738) B (number = 3,089) AB (number = 1,102) Non-O (number = 7,929)
Total cholesterol a 202.9 (43.5) 205.6 (43.8)** 200.5 (41.7)* 201.0 (41.3) 203.0 (42.7)
HDL 59.4 (14.8) 59.9 (14.8) 59.2 (14.4) 59.1 (14.5) 59.5 (14.6)
LDL 116.2 (36.1) 118.8 (35.4)** 114.2 (34.4)* 115.9 (34.5) 116.6 (35.0)
Triglycerides 139.8 (98.3) 139.2 (102.0) 139.3 (98.9) 132.3 (77.9)* 138.3 (97.8)
FBG 103.7 (39.5) 105.6 (41.1) 104.8 (40.7) 106.0 (45.3)* 105.4 (41.6)*
Systolic blood pressure 125.8 (20.9) 125.7 (20.6) 125.7 (21.0) 124.9 (20.5) 125.6 (20.8)
Diastolic blood pressure 77.8 (12.5) 77.4 (12.5) 77.5 (12.6) 77.7 (12.4) 77.5 (12.5)
BMI 27.1 (5.3) 27.1 (5.3) 27.1 (5.4) 27.0 (5.3) 27.1 (5.3)
Waist circumference 94.6 (13.8) 94.6 (13.8) 94.6 (14.1) 94.2 (14.0) 94.5 (13.9)
  1. aNumbers are mean (standard deviation). *P <0.05, **P < 0.01. P values adjusted for age, sex, place of residence, education, smoking in pack-years, opium use, and socioeconomic status. Blood lipids and glucose models were also adjusted for BMI. BMI: body mass index; FBG: fasting blood glucose; HDL: high-density lipoproteins; LDL: low-density lipoproteins.